Association of reported fish intake and supplementation status with the omega-3 index

K. H. Jackson, J. M. Polreis, N. L. Tintle, Penny Margaret Kris-Etherton, W. S. Harris

Research output: Contribution to journalArticle

Abstract

Background: An Omega-3 Index (O3I; EPA+DHA as a % of erythrocyte total fatty acids) in the desirable range (8%-12%) has been associated with improved heart and brain health. Objective: To determine the combination of fish intake and supplement use that is associated with an O3I of >8%. Design: Two cross-sectional studies comparing the O3I to EPA+DHA/fish intake. Participants/setting: The first study included 28 individuals and assessed their fish and EPA+DHA intake using both a validated triple-pass 24-hr recall dietary survey and a single fish-intake question. The second study used de-identified data from 3,458 adults (84% from US) who self-tested their O3I and answered questions about their fish intake and supplement use. Statistical analyses performed: Study 1, chi-squared, one-way ANOVA, and Pearson correlations were computed. In Study 2, multi-variable regression models were used to predict O3I levels from reported fish/supplement intakes. Results: The mean ± SD O3I was 4.87 ± 1.32%, and 5.99 ± 2.29% in the first and second studies, respectively. Both studies showed that for every increase in fish intake category the O3I increased by 0.50–0.65% (p < 0.0001). In the second study, about half of the population was taking omega-3 supplements, 32% reported no fish intake and 17% reported eating fish >2 times per week. Taking an EPA+DHA supplement increased the O3I by 2.2% (p < 0.0001). The odds of having an O3I of ≥8% were 44% in the highest intake group (≥3 servings/week and supplementation) and 2% in the lowest intake group (no fish intake or supplementation); and in those consuming 2 fish meals per week but not taking supplements (as per recommendations), 10%. Conclusions: Current AHA recommendations are unlikely to produce a desirable O3I. Consuming at least 3 fish servings per week plus taking an EPA+DHA supplement markedly increases the likelihood of achieving this target level.

Original languageEnglish (US)
Pages (from-to)4-10
Number of pages7
JournalProstaglandins Leukotrienes and Essential Fatty Acids
Volume142
DOIs
StatePublished - Mar 1 2019

Fingerprint

Fish
Fishes
Analysis of variance (ANOVA)
Meals
Brain
Analysis of Variance
Fatty Acids
Cross-Sectional Studies
Erythrocytes
Health

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry
  • Cell Biology

Cite this

@article{c6c9acbc40f843e5a633bc18da993873,
title = "Association of reported fish intake and supplementation status with the omega-3 index",
abstract = "Background: An Omega-3 Index (O3I; EPA+DHA as a {\%} of erythrocyte total fatty acids) in the desirable range (8{\%}-12{\%}) has been associated with improved heart and brain health. Objective: To determine the combination of fish intake and supplement use that is associated with an O3I of >8{\%}. Design: Two cross-sectional studies comparing the O3I to EPA+DHA/fish intake. Participants/setting: The first study included 28 individuals and assessed their fish and EPA+DHA intake using both a validated triple-pass 24-hr recall dietary survey and a single fish-intake question. The second study used de-identified data from 3,458 adults (84{\%} from US) who self-tested their O3I and answered questions about their fish intake and supplement use. Statistical analyses performed: Study 1, chi-squared, one-way ANOVA, and Pearson correlations were computed. In Study 2, multi-variable regression models were used to predict O3I levels from reported fish/supplement intakes. Results: The mean ± SD O3I was 4.87 ± 1.32{\%}, and 5.99 ± 2.29{\%} in the first and second studies, respectively. Both studies showed that for every increase in fish intake category the O3I increased by 0.50–0.65{\%} (p < 0.0001). In the second study, about half of the population was taking omega-3 supplements, 32{\%} reported no fish intake and 17{\%} reported eating fish >2 times per week. Taking an EPA+DHA supplement increased the O3I by 2.2{\%} (p < 0.0001). The odds of having an O3I of ≥8{\%} were 44{\%} in the highest intake group (≥3 servings/week and supplementation) and 2{\%} in the lowest intake group (no fish intake or supplementation); and in those consuming 2 fish meals per week but not taking supplements (as per recommendations), 10{\%}. Conclusions: Current AHA recommendations are unlikely to produce a desirable O3I. Consuming at least 3 fish servings per week plus taking an EPA+DHA supplement markedly increases the likelihood of achieving this target level.",
author = "Jackson, {K. H.} and Polreis, {J. M.} and Tintle, {N. L.} and Kris-Etherton, {Penny Margaret} and Harris, {W. S.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.plefa.2019.01.002",
language = "English (US)",
volume = "142",
pages = "4--10",
journal = "Prostaglandins Leukotrienes and Essential Fatty Acids",
issn = "0952-3278",
publisher = "Churchill Livingstone",

}

Association of reported fish intake and supplementation status with the omega-3 index. / Jackson, K. H.; Polreis, J. M.; Tintle, N. L.; Kris-Etherton, Penny Margaret; Harris, W. S.

In: Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 142, 01.03.2019, p. 4-10.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Association of reported fish intake and supplementation status with the omega-3 index

AU - Jackson, K. H.

AU - Polreis, J. M.

AU - Tintle, N. L.

AU - Kris-Etherton, Penny Margaret

AU - Harris, W. S.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Background: An Omega-3 Index (O3I; EPA+DHA as a % of erythrocyte total fatty acids) in the desirable range (8%-12%) has been associated with improved heart and brain health. Objective: To determine the combination of fish intake and supplement use that is associated with an O3I of >8%. Design: Two cross-sectional studies comparing the O3I to EPA+DHA/fish intake. Participants/setting: The first study included 28 individuals and assessed their fish and EPA+DHA intake using both a validated triple-pass 24-hr recall dietary survey and a single fish-intake question. The second study used de-identified data from 3,458 adults (84% from US) who self-tested their O3I and answered questions about their fish intake and supplement use. Statistical analyses performed: Study 1, chi-squared, one-way ANOVA, and Pearson correlations were computed. In Study 2, multi-variable regression models were used to predict O3I levels from reported fish/supplement intakes. Results: The mean ± SD O3I was 4.87 ± 1.32%, and 5.99 ± 2.29% in the first and second studies, respectively. Both studies showed that for every increase in fish intake category the O3I increased by 0.50–0.65% (p < 0.0001). In the second study, about half of the population was taking omega-3 supplements, 32% reported no fish intake and 17% reported eating fish >2 times per week. Taking an EPA+DHA supplement increased the O3I by 2.2% (p < 0.0001). The odds of having an O3I of ≥8% were 44% in the highest intake group (≥3 servings/week and supplementation) and 2% in the lowest intake group (no fish intake or supplementation); and in those consuming 2 fish meals per week but not taking supplements (as per recommendations), 10%. Conclusions: Current AHA recommendations are unlikely to produce a desirable O3I. Consuming at least 3 fish servings per week plus taking an EPA+DHA supplement markedly increases the likelihood of achieving this target level.

AB - Background: An Omega-3 Index (O3I; EPA+DHA as a % of erythrocyte total fatty acids) in the desirable range (8%-12%) has been associated with improved heart and brain health. Objective: To determine the combination of fish intake and supplement use that is associated with an O3I of >8%. Design: Two cross-sectional studies comparing the O3I to EPA+DHA/fish intake. Participants/setting: The first study included 28 individuals and assessed their fish and EPA+DHA intake using both a validated triple-pass 24-hr recall dietary survey and a single fish-intake question. The second study used de-identified data from 3,458 adults (84% from US) who self-tested their O3I and answered questions about their fish intake and supplement use. Statistical analyses performed: Study 1, chi-squared, one-way ANOVA, and Pearson correlations were computed. In Study 2, multi-variable regression models were used to predict O3I levels from reported fish/supplement intakes. Results: The mean ± SD O3I was 4.87 ± 1.32%, and 5.99 ± 2.29% in the first and second studies, respectively. Both studies showed that for every increase in fish intake category the O3I increased by 0.50–0.65% (p < 0.0001). In the second study, about half of the population was taking omega-3 supplements, 32% reported no fish intake and 17% reported eating fish >2 times per week. Taking an EPA+DHA supplement increased the O3I by 2.2% (p < 0.0001). The odds of having an O3I of ≥8% were 44% in the highest intake group (≥3 servings/week and supplementation) and 2% in the lowest intake group (no fish intake or supplementation); and in those consuming 2 fish meals per week but not taking supplements (as per recommendations), 10%. Conclusions: Current AHA recommendations are unlikely to produce a desirable O3I. Consuming at least 3 fish servings per week plus taking an EPA+DHA supplement markedly increases the likelihood of achieving this target level.

UR - http://www.scopus.com/inward/record.url?scp=85060082997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060082997&partnerID=8YFLogxK

U2 - 10.1016/j.plefa.2019.01.002

DO - 10.1016/j.plefa.2019.01.002

M3 - Article

VL - 142

SP - 4

EP - 10

JO - Prostaglandins Leukotrienes and Essential Fatty Acids

JF - Prostaglandins Leukotrienes and Essential Fatty Acids

SN - 0952-3278

ER -